During the past decade, Central Maine Heart & Vascular Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Maine Heart & Vascular Institute" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Central Maine Heart & Vascular Institute" are "Arthritis, Rheumatoid" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Central Maine Heart & Vascular Institute" in a lesser frequency.

Most popular intervention types in "Central Maine Heart & Vascular Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ibuprofen" (1 trials), "Naproxen" (1 trials), "apixaban" (1 trials), "celecoxib" (1 trials) and "warfarin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Maine Heart & Vascular Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central Maine Heart & Vascular Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central Maine Heart & Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Maine Heart & Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".